You are here: University of Sydney / Faculty of Pharmacy / Academic Staff / Associate Professor Sallie-Anne Pearson 

Associate Professor Sallie-Anne Pearson

BSc (Hons) PhD
Head, Pharmacoepidemiology and Pharmaceutical Policy Research Group

A15 - Pharmacy And Bank Building
The University of Sydney

Telephone +61 2 9036 7023
Fax +61 2 9351 4391

Biographical details

Sallie is a health service researcher and behavioural scientist with more than 15 years of experience in quality use of medicines research. Her interests include prescriber behaviour change, post-market surveillance of medicines and evaluating the impact of pharmaceutical policy interventions. Sallie completed her doctoral training at the University of Newcastle, Australia (1998) and her Postdoctoral Fellowship in Pharmaceutical Policy at Harvard Medical School (2000-2001). On her return to Australia she worked as a consultant to the WHO Collaborating Centre in Pharmaceutical Policy Boston and Medicare Australia. She established the Pharmacoepidemiology and Pharmaceutical Policy Research Group in 2006 and joined the Faculty of Pharmacy, University of Sydney in 2012. She is currently a Cancer Institute NSW Career Development Fellow.

Back to Top

Research interests

  • Quality use of medicines
  • Pharmacoepidemiology
  • Health Services Research
  • Clinician Behaviour Change
  • Cancer

Back to Top

Associations

  • Chair, NSW Health and Cancer Institute NSW, Population & Health Services Research Ethics Committee
  • Chair, National Prescribing Service: MedicineInsight Data Governance Expert Reference Group
  • Member, Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee
  • Member, NSW Translational Bioinformatics Working Group
  • Member, Sydney Catalyst Translational Cancer Research Consortium: T2 Working Group
  • Member, Cancer Research Network, University of Sydney
  • Member, Centre for Disability Research, Management Committee, Faculty of Health Sciences, University of Sydney
  • Member, Health Data Linkage Group, The University of Sydney
  • Member, Cancer Research Economics Support Team (CREST)
  • Member, Health Service Research Association of Australia and New Zealand
  • Member, International Society of Pharmacoepidemiology
  • Member, Harvard Club of Australia

Back to Top

Selected grants

2013

  • Post-market surveillance of cancer medicines: Generating evidence for clinical and policy practice using linked health administrative data; Pearson S; Cancer Institute New South Wales/Career Development Fellowship.
  • The use and impact of high cost targeted cancer medicines: theory and reality; Pearson S, Ward R, Dobbins T, Lu C; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2012

  • Should I take low dose aspirin? Development of the Optimise decision aid for cancer chemoprophylaxis; Trevena L, Dowie J, Pearson S, Howard K, Olver I, Zannino D; Sydney Catalyst Translational Cancer Research/Pilot and Seed Funding.
  • High risk prescribing in older Australians; Banks E, Le Couteur D, Pearson S, McLachlan A, Viney R, Hilmer S, Gnjidic D, Blyth F; National Health and Medical Research Council/Project Grants.

2010

  • Measuring the use and impact of the Cancer Institute Standard Cancer Treatments Program in NSW hospitals; Pearson S, Ward R; Cancer Institute New South Wales/Translational Program Grant.
  • The use, effectiveness and safety of cancer medicines in the real world clinical setting; Pearson S; Cancer Institute New South Wales/Career Development Fellowship.

2009

  • Building capacity in innovative approaches to health technology assessment; Viney R, Haas M, Pearson S, van Gool K; National Health and Medical Research Council/Strategic Awards: Capacity Building Grants for Population Health and Health Services.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Langton, J., Pearson, S. (2013). Electronic Decision Support Systems for Prescribing: Challenges and Perspectives for Personalized Medicine. In I. S Vizirianakis (Eds.), Handbook of Personalized Medicine: Advances in Nanotechnology, Drug Delivery and Therapy. Pan Stanford Publishing.

Journals

  • Srasuebkul, P., Dobbins, T., Pearson, S. (2013). Validation of a proxy for estrogen receptor status in breast cancer patients using dispensing data. Asia Pacific Journal of Clinical Oncology.
  • Banks, E., Pearson, S. (2012). A life-cycle approach to monitoring benefits and harms of medicines: Collection of high-quality data and management of risk are ongoing needs. Medical Journal of Australia, 197(6), 313-314.
  • Cohen, S., Lawson, J., Graudins, L., Pearson, S., Gazarian, M. (2012). Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality Use of Medicines. Journal of Paediatrics and Child Health, 48(6), 490-495.
  • Haywood, P., de Raad, J., van Gool, K., Haas, M., Gallego, G., Pearson, S., Faedo, M., Ward, R. (2012). Chemotherapy administration: Modelling the costs of alternative protocols. PharmacoEconomics, 30(12), 1173-1186.
  • Stavrou, E., Buckley, N., Olivier, J., Pearson, S. (2012). Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. BMJ Open, 2(3), 1-6.
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2012). Governance approval for multisite, non-interventional research: what can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience? Internal Medicine Journal, 42(2), 127-131.
  • Stavrou, E., Pesa, N., Pearson, S. (2012). Hospital discharge diagnostic and procedure codes for upper gastro-intestinal cancer: how accurate are they? BMC Health Services Research, 12(1), 1-7.
  • Hains, I., Ward, R., Pearson, S. (2012). Implementing a web-based oncology protocol system in Australia: evaluation of the first 3 years of operation. Internal Medicine Journal, 42(1), 57-64.
  • Langton, J., Pearson, S. (2012). Improving the quality of oncology guidelines and protocols. Asia Pacific Journal of Clinical Oncology, 8(3), 313-313.
  • Stavrou, E., Ward, R., Pearson, S. (2012). Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data. BMC Health Services Research, 12(1), 1-10.
  • Robertson, J., McElduff, P., Pearson, S., Henry, D., Inder, K., Attia, J. (2012). The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Services Research, 12, 1-11.
  • Stavrou, E., Lu, C., Buckley, N., Pearson, S. (2012). The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients. Annals of Oncology, 23(9), 2422-2428.
  • Mealing, N., Dobbins, T., Pearson, S. (2012). Validation and application of the death proxy in adult cancer patients. Pharmacoepidemiology and Drug Safety: an international journal, 21(7), 742-748.
  • Robertson, J., Moxey, A., Newby, D., Gillies, M., Williamson, M., Pearson, S. (2011). Electronic information and clinical decision support for prescribing: State of play in Australian general practice. Journal Of Family Practice, 28(1), 93-101.
  • Langton, J., Pearson, S. (2011). eviQ cancer treatments online: How does the web-based protocol system fare in a comprehensive quality assessment? Asia Pacific Journal of Clinical Oncology, 7(4), 357-363.
  • Lu, C., Srasuebkul, P., Drew, A., Ward, R., Pearson, S. (2011). Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Internal Medicine Journal, (Online preview).
  • Harris, C., Ward, R., Dobbins, T., Drew, A., Pearson, S. (2011). The efficacy of HER2 targeted agents in metastatic breast cancer: A meta-analysis. Annals of Oncology, 22, 1308-1317.
  • Langton, J., Drew, A., Mellish, L., Olivier, J., Ward, R., Pearson, S. (2011). The quality of web-based oncology guidelines and protocols: how do international sites stack up? British Journal of Cancer, 105(8), 1166-1172.
  • Stavrou, E., Vagdic, C., Loxton, D., Pearson, S. (2011). The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiology, 35, e75-e80.
  • Moxey, A., Robertson, J., Newby, D., Hains, I., Williamson, M., Pearson, S. (2010). Computerized clinical decision support for prescribing: provision does not guarantee uptake. Journal of the American Medical Informatics Association, 17(1), 25-33.
  • de Raad, J., van Gool, K., Haas, M., Haywood, P., Faedo, M., Gallego, G., Pearson, S., Ward, R. (2010). Nursing takes time: workload associated with administering cancer protocols. Clinical Journal of Oncology Nursing, 14(6), 735-741.
  • Pearson, S., Chin, M., Faedo, M., Ward, R. (2010). Rationale for treatment durations of targeted cancer agents. Lancet Oncology, 11(12), 1113-1115.
  • Robertson, J., Walkom, E., Pearson, S., Hains, I., Williamsone, M., Newby, D. (2010). The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. International Journal of Pharmacy Practice, 18(2), 69-87.
  • Pearson, S., Moxey, A., Robertson, J., Hains, I., Williamson, M., Reeve, J., Newby, D. (2009). Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Services Research, 9.
  • Garvey, G., Rolfe, I., Pearson, S., Treloar, C. (2009). Indigenous Australian medical students' perceptions of their medical school training. Medical Education, 43(11), 1047-1055.
  • Hains, I., Fuller, J., Ward, R., Pearson, S. (2009). Standardizing care in medical oncology: Are web-based systems the answer? Cancer, 115(23), 5579-5588.
  • Lane, C., Healy, C., Ho, M., Pearson, S., Brown, M. (2008). How to attract a nephrology trainee: Quantitative questionnaire results. Nephrology, 13(2), 116-123.
  • Lu, C., Ross-Degnan, D., Soumerai, S., Pearson, S. (2008). Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Services Research, 8.
  • Ringland, C., Mant, A., McGettigan, P., Mitchell, P., Kelman, C., Buckley, N., Pearson, S. (2008). Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data. British Journal of Clinical Pharmacology, 66(5), 682-688.
  • Kelman, C., Pearson, S., Day, R., Holman, C., Kliewer, E., Henry, D. (2007). Evaluating Medicines: let's use all the evidence. Internal Medicine Journal, 186(5), 249-252.
  • Pearson, S., Ringland, C., Kelman, C., Mant, J., Lowinger, J., Stark, H., Nichol, G., Day, R., Henry, D. (2007). Patterns of analgesic and anti-inflammatory medicine use by Australian veterans. Internal Medicine Journal, 37(12), 798-805.
  • Pearson, S., Ringland, C., Ward, R. (2007). Trastuzumab and metastatic breast cancer: Trastuzumab use in Australia - Monitoring the effect of an expensive medicine access program. Journal of Clinical Oncology, 25(24), 3688-3693.
  • Pearson, S., Ringland, C., Ward, R. (2007). Use of Trastuzumab for metastatic breast cancer in Australia: interpreting findings from a cohort of 1,469 women on a national access program versus 41 women treated by two medical oncologists. Journal of Clinical Oncology, 25(35), 5663-5664.
  • Tan, E., Stark, H., Lowinger, J., Ringland, C., Ward, R., Pearson, S. (2006). Information Sources used by New South Wales cancer clinicians: a qualitative study. Internal Medicine Journal, 36(11), 711-717.
  • Pearson, S., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L., Fanning, T., Gallagher, P., Ross-Degnan, D. (2006). Racial disparities in access after regulatory surveillance of benzodiazepines. Archives of Internal Medicine, 166(5), 572-579.
  • Rolfe, I., Ringland, C., Pearson, S. (2004). Graduate entry to medical school? Testing some assumptions. Medical Education, 38(7), 778-786.
  • Pearson, S., Ross-Degnan, D., Payson, A., Soumerai, S. (2003). Changing medication use in managed care: A critical review of the available evidence. American Journal of Managed Care, 9(11), 715-731.
  • Pearson, S., Rolfe, I., Ringland, C., Kay-Lambkin, F. (2002). A comparison of practice outcomes of graduates from traditional and non-traditional medical schools in Australia. Medical Education, 36(10), 985-991.
  • Pearson, S., Rolfe, I., Smith, T. (2002). Factors influencing prescribing: An intern's perspective. Medical Education, 36(8), 781-787.
  • Pearson, S., Rolfe, I., Smith, T., O'Connell, D. (2002). Intern prescribing decisions: Few and far between. Education for Health, 15(3), 315-325.
  • Mooney, W., Cole, I., Albsoul, N., Pearson, S. (2002). Salvage vertical partial laryngectomy for radiation failure in early glottic carcinoma. ANZ Journal of Surgery, 72(10), 746-749.
  • Kay-Lambkin, F., Pearson, S., Rolfe, I. (2002). The influence of admissions variables on first year medical school performance: A study from Newcastle University. Medical Education, 36(2), 154-159.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C., Bayley, S., Hart, A., Kelly, S. (2002). Which common clinical conditions should medical students be able to manage by graduation? A perspective from Australian interns. Medical Teacher, 24(1), 16-22.
  • Grey, M., Pearson, S., Rolfe, I., Kay, F., Powis, D. (2001). How do australian doctors with different pre-medical school backgrounds perform as interns? Education for Health, 14(1), 87-96.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C. (2001). Identifying medical school learning needs: A survey of Australian interns. Education for Health, 14(3), 395-404.
  • Clercq, L., Pearson, S., Rolfe, I. (2001). The relationship between previous tertiary education and course performance in first year medical students at Newcastle University. Education for Health, 14(3), 417-426.
  • Garvey, G., Rolfe, I., Pearson, S. (2000). Agents for social change: The University of Newcastle's role in graduating Australian Aboriginal doctors. Focus on Health Professional Education: a multi-disciplinary journal, 2(2), 18-27.
  • Treloar, C., McCall, N., Rolfe, I., Pearson, S., Garvey, G., Heathcote, A. (2000). Factors affecting progress of Australian and international students in a prolem-based learning medical course. Medical Education, 34(9), 708-715.
  • Pearson, S., Smith, A., Rolfe, I., Moulds, R., Shenfield, G. (2000). Intern prescribing for common clinical conditions. Advances in Health Sciences Education, 5(2), 141-150.
  • Enno, A., Mondy, P., Kerridge, R., Pearson, S. (2000). Investigating pathology utilisation by junior medical staff in a teaching hospital: a qualitative study. Australian and New Zealand Journal of Medicine, 30(2), 261-263.
  • Rolfe, I., Pearson, S., Cleary, E., Gannon, C. (1999). Attitudes towards community medicine: a comparison of students from traditional and community-oriented medical schools. Medical Education, 33(8), 606-611.
  • Kerridge, I., Pearson, S., Rolfe, I., Lowe, M. (1999). Decision making in CPR. Medical Journal of Australia, 170, 45-46.
  • Kerridge, I., Pearson, S., Rolfe, I., Lowe, M., McPhee, J. (1999). Impact of written information on knowledge and preferences for cardiopulmonary resuscitation. Medical Journal of Australia, 171(5), 239-242.
  • Rolfe, I., Gordon, F., Atherton, S., Pearson, S., Kay, F., Fardell, S. (1998). A system for maintaining the educational and training standards of junior doctors. Medical Education, 32(4), 426-431.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Fardell, S., Kay, F., Gordon, J. (1998). Measuring the hospital experiences of junior doctors. Medical Education, 32(3), 312-319.
  • Rolfe, I., Pearson, S., Fardell, S., Kay, F. (1998). Monitoring the performance of junior doctors in the first two years of postgraduate training. Education for Health, 11.
  • Pearson, S., Rolfe, I., Henry, R. (1998). The relationship between assessment measures at Newcastle Medical School (Australia) and performance ratings during internship. Medical Education, 32(1), 40-45.

Conferences

  • Lu, C., Srasuebkul, P., Ward, R., Pearson, S. (2011). Cardiotoxic Cancer Therapies in Australia: Which Patients are Assessed for Cardiac Function?. International Society of Pharmacoepidemiology Meeting 2011, Chicago, IL.
  • Joshi, V., Srasuebkul, P., Adelstein, B., Dobbins, T., Pearson, S. (2011). Estimating disease progression in patients with metastatic disease using prescribing data: A pilot validation study. Australian Epidemiological Association (AEA) Annual Conference 2011, Perth, WA.
  • Langton, J., Pearson, S. (2011). Online Resources for Cancer Care: A Quality Assessment of Evidence-Based Guidelines and Protocols. 33rd Annual Meeting of the Society for Medical Decision Making SMDM 2011.
  • Lu, C., Srasuebkul, P., Drew, A., Ward, R., Pearson, S. (2011). Spillover effects of prescribing restrictions for trastuzumab in Australia. Third International Conference for Improving Use of Medicines.
  • Pearson, S., Srasuebkul, P., Dobbins, T., Lu, C., Ward, R. (2011). The Impact of Evidence-Based Subsidy Restrictions on Lapatinib Use and Outcomes. International Society of Pharmacoepidemiology Meeting 2011, Chicago, IL.
  • Pearson, S., Srasuebkul, P., Lu, C., Dobbins, T., Ward, R. (2011). The impact of evidence-based subsidy restrictions on prescriber behaviour and patient outcomes: A case study of lapatinib for the treatment of HER2+ metastatic breast cancer. Third International Conference for Improving Use of Medicines.
  • Pearson, S., Drew, A., Langton, J. (2011). The quality of a local web-based oncology protocol system: how does eviQ compare to similar websites internationally?. Medicines Management 2011, the 37th Society of Hospital Pharmacists of Australia (SHPA) National Conference.
  • Stavrou, E., Buckley, N., Lu, C., Pearson, S. (2011). The Role of Comorbidity in the Uptake of Chemotherapy and Cancer Survival. International Society of Pharmacoepidemiology Meeting 2011, Chicago, IL.
  • Pearson, S. (2010). Analysis of outcomes from trastuzumab (Herceptin) use in Australia. Combining Health Economics and Econometrics for Technology Assessment in Australia Annual Investigators Meeting, Sydney.
  • Cohen, S., Lawson, J., Graudins, L., Pearson, S., Gazarian, M. (2010). Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality Use of Medicines (QUM). National Medicines Symposium 2010, Melbourne.
  • Dobbins, T., Srasuebkul, P., Stavrou, E., Pearson, S. (2010). Concurrentplot: a SAS macro to graphically display concurrent pharmaceutical use based on claims data. 5th Asian Meeting of the International Society of Pharmacoepidemiology, Tokyo, Japan: International Society for Pharmacoepidemiology.
  • Chen, K., He, J., Or, M., Srasuebkul, P., Pearson, S. (2010). Exploring the differences in resource utilisation for breast cancer chemotherapy in public and private hospitals in NSW. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2010). Governance approval for multisite, non-interventional research: what can HoMER learn from the NSW experience?. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Harris, C., Pearson, S., Dobbins, T., Drew, A., Ward, R. (2010). HER2 targeted agents improve overall survival in HER2+ metastatic breast cancer (MBC): A meta-analysis. Medical Oncology Group of Australia Annual Scientific Meeting, Sydney, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Stavrou, E., Dobbins, T., Lu, C., Srasuebkul, P., Pearson, S. (2010). Lack of uptake of chemotherapy for colorectal cancer in Australian veterans. 5th Asian Meeting of the International Society of Pharmacoepidemiology, Tokyo, Japan: International Society for Pharmacoepidemiology.
  • Pearson, S. (2010). More is better: Durations of trastuzumab therapy in Phase III clinical trials for HER2 positive metastatic breast cancer. National Medicines Symposium 2010, Melbourne.
  • Pearson, S., Srasuebkul, P., Stavrou, E., Ward, R., Dobbins, T. (2010). New HER2 therapies for metastatic breast cancer: Are prescribers the obstacle to access in Australia?. International Society of Pharmacoepidemiology 5th Asian Meeting, Tokyo.
  • Stavrou, E., Mealing, N., Dobbins, T., Pearson, S. (2010). Patterns of drug treatment for colorectal cancer (CRC) in New South Wales. Australian Epidemiological Association (AEA) Annual Conference 2010, Sydney, NSW.
  • Srasuebkul, P., Pearson, S., Harris, C., Ward, R., Dobbins, T. (2010). The impact of oestrogen receptor (ER) status on overall survival of metastatic breast cancer patients receiving trastuzumab in Australia. 16th Annual Japanese Society for Pharmacoepidemiology Meeting and the 5th Annual Asian Conference on Pharmacoepidemiology, Japan: ACPE.
  • Pearson, S., Srasuebkul, P., Harris, C., Ward, R., Dobbins, T. (2010). Trastuzumab (T) treatment outcomes according to concomitant chemotherapy regimen: Overall survival (OS) of HER2+ metastatic breast cancer (MBC) patients. 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Brighton, UK: International Society for Pharmacoepidemiology.
  • Srasuebkul, P., Pearson, S., Harris, C., Ward, R., Dobbins, T. (2010). Trastuzumab (T) treatment outcomes according to estrogen receptor (ER) status: Overall survival (OS) of HER2+ metastatic breast cancer (MBC) patients. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • He, J., Or, M., Chen, K., Srasuebkul, P., Pearson, S. (2010). Treatment pathways and resource utilisation in advanced/metastatic non-small-cell lung cancer patients undergoing chemotherapy. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Mealing, N., Pearson, S., Srasuebkul, P., Stavrou, E., Dobbins, T. (2010). Validation and application of a death proxy in metastatic cancer patients. 5th Asian Meeting of the International Society of Pharmacoepidemiology, Tokyo, Japan: International Society for Pharmacoepidemiology.
  • Mealing, N., Dobbins, T., Srasuebkul, P., Stavrou, E., Pearson, S. (2010). Validation of a death proxy in adult cancer patients. Australian Epidemiological Association (AEA) Annual Conference 2010, Sydney, NSW.
  • Stavrou, E., Loxton, D., Vajdic, C., Pearson, S. (2010). Validation of self-reported cancer and predictors of false reports in Australian women. Australian Epidemiological Association (AEA) Annual Conference 2010, Sydney, NSW.
  • Pearson, S. (2010). What are the secrets to a successful health services research grant application?. HSRAANZ Workshop 2010, Sydney, NSW.
  • Pearson, S. (2009). Application of Pharmacoepidemiology Research for Policy Making. 4th Asian Conference on Pharmacoepidemiology, Taiwan.
  • Pearce, A., Haas, M., Haywood, P., van Gool, K., Gallego, G., Pearson, S. (2009). Chemotherapy, adverse events and costs. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Pearson, S. (2009). Current research in cancer pharmacoepidemiology. 6th Annual 45 and Up Study Collaborators Meeting, Sydney.
  • Pearson, S. (2009). Economic modelling applied to cancer treatment protocols - EM-CAP. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Faedo, M., Pearson, S., Bastick, P., van Gool, K., Haywood, P., Haas, M., Ward, R. (2009). Elements of cancer care study: Tracking resource utilisation and costs in a cohort of NSW cancer patients. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Pearson, S. (2009). Ethics approval for data linkage studies: What really counts?. Health Data Linkage Workshop 2009, Newcastle, NSW.
  • Robertson, J., Pearson, S. (2009). Improving the uptake of drug information and decision support. National Prescribing Service Research and Development Working Group 2009, Sydney.
  • Robertson, J., McElduff, P., Pearson, S., Henry, D., Inder, K., Attia, J. (2009). The burden of heart failure hospitalisations in NSW. Health Data Linkage Workshop 2009, Newcastle, NSW.
  • Pearson, S., Chin, M., Ward, R. (2009). The financially tolerable dose: A new concept in clinical trial design?. 25th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Providence, USA: International Society for Pharmacoepidemiology.
  • Pearson, S. (2009). Using health administrative data to evaluate pharmaceutical access programs in Australia. UNSW Psychosocial Research Group, Sydney.
  • Pearson, S., Faedo, M., van Gool, K., Haas, M., Ward, R. (2009). Using routinely collected health data to inform economic models of cancer care. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Hains, I., Pearson, S. (2008). A nurses perspective on barriers to the uptake of CI-SCaT in Australian hospitals. CI-SCaT Nurses Reference Group Workshop 2008, Sydney: Cancer Institute NSW.
  • Cohen, S., Lawson, J., Graudins, L., Gazarian, M., Pearson, S. (2008). Anticonvulsant prescribing for the Australian paediatric population. TOW Research Awards, Sydney: TOW Society.
  • Hains, I., Bichel-Findlay, J., Rushton, S., Booth, A., Ward, R., Pearson, S. (2008). Barriers to using web-based chemotherapy protocols in Australian hospitals - The nurse perspective. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Ringland, C., Pearson, S., Ward, R. (2008). Cardiovascular medicine use in women receiving trastuzumab for HER-2 positive metastatic breast cancer. Sydney Cancer Conference 2008 (SCC2008), Sydney: University of Sydney.
  • Cheong, L., Ward, R., Pearson, S. (2008). Dosing guidelines for cytotoxic cancer chemotherapy: Theory versus reality. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Moxey, A., Newby, D., Robertson, J., Williamson, M., Hains, I., Pearson, S. (2008). Electronic design support for prescribing decisions in primary care: Does it work?. General Practice and Primary Health Care Research Conference GP & PHC 2008, Hobart, Australia: Primary Health Care Research and Information Service.
  • Moxey, A., Newby, D., Robertson, J., Williamson, M., Hains, I., Pearson, S. (2008). Electronic design support for prescribing decisions: Does it work?. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Hains, I., Ward, R., Pearson, S. (2008). Evaluating CI-SCaT use in NSW hospitals. Cancer Institute NSW Cancer Services and Education Research Meeting 2008, Sydney: Cancer Institute NSW.
  • Pearson, S. (2008). Evaluating medicines use outside trial conditions: Making best use of secondary health data. The 5th Annual Future of the PBS Conference, Sydney.
  • Pearson, S. (2008). Evaluating the impact on cancer interventions using secondary health data. University of New South Wales International Research Workshop 2008, Sydney: University of New South Wales.
  • Pearson, S. (2008). Getting your data linkage project through ethics the first time: A researcher and committee member perspective. University of Newcastle Health Data Linkage Meeting 2008, Newcastle: University of Newcastle.
  • Moxey, A., Pearson, S., Williamson, M., Gillies, M., Newby, D., Robertson, J. (2008). GPs' use of computer-based information sources in clinical practice - What, when, how?. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Moxey, A., Pearson, S., Williamson, M., Gillies, M., Newby, D., Robertson, J. (2008). GPs' use of computer-based information sources in clinical practice - What, when, how?. General Practice and Primary Health Care Research Conference GP & PHC 2008, Hobart, Australia: Primary Health Care Research and Information Service.
  • Moxey, A., Pearson, S., Robertson, J., Hains, I., Williamson, M., Newby, D. (2008). Influences on the use of electronic decision support in prescribing. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Moxey, A., Pearson, S., Robertson, J., Hains, I., Williamson, M., Newby, D. (2008). Influences on the use of prescribing electronic decision support. General Practice and Primary Health Care Research Conference GP & PHC 2008, Hobart, Australia: Primary Health Care Research and Information Service.
  • Pearson, S., Ringland, C., Ward, R. (2008). Lessons learnt from an evaluation of The Herceptin National Access Program for metastatic breast cancer. Sydney Cancer Conference 2008 (SCC2008), Sydney: University of Sydney.
  • Pearson, S., Ringland, C., Ward, R. (2008). Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer. 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management 2008, Copenhagen, Denmark: International Society for Pharmacoepidemiology.
  • Bastick, P., Faedo, M., Van Gool, K., Pearson, S., Haas, M., Ward, R. (2008). Rationing high cost cancer medicines: Building the evidence base to support local decision makers. MOGA/FRO/NZSO/NZACS Joint Scientific Meeting, Christchurch: Wiley.
  • Pearson, S., Lawrence, G. (2008). Research opportunities using linked health data. University of New South Wales Research Seminar 2008, Sydney: University of New South Wales.
  • Pearson, S. (2008). Rules and definitions in the analysis of PBS data. National Prescribing Service: Working with PBS Data Workshop 2008, Sydney: National Prescribing Service Ltd.
  • Ringland, C., Pearson, S., Ward, R. (2008). Survival of women treated with trastuzumab for HER-2 positive metastatic breast cancer: Estimating outcomes in clinical practice with administrative data. 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management 2008, Copenhagen, Denmark: International Society for Pharmacoepidemiology.
  • Hains, I., Bichel-Findlay, J., Rushton, S., Ward, R., Pearson, S. (2008). The use of web-based chemotherapy protocols in Australian hospitals: Barriers to their uptake - The nurse perspective. 11th Cancer Nurses Society of Australia Winter Congress, Gold Coast: Cancer Nurses Society of Australia.
  • Cohen, S., Lawson, J., Graudins, L., Gazarian, M., Pearson, S. (2008). Trends in anticonvulsant prescribing in the Australian paediatric population: 2002-2007. 23rd Epilepsy Society Australia Annual Scientific Meeting, Sydney, Australia: Epilepsy Society of Australia.
  • Faedo, M., van Gool, K., Pearson, S., Haas, M., Ward, R. (2008). Using clinical and economic evidence to inform local decision making in cancer care. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Hains, I., Bichel-Findlay, J., Rushton, S., Booth, A., Ward, R., Pearson, S. (2008). Web-based chemotherapy protocols - A help or hindrance?. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Hains, I., Rushton, S., Bichel-Findlay, J., Booth, A., Ward, R., Pearson, S. (2008). Web-based chemotherapy protocols - friend or foe?. Centre for Health Informatics Seminar Series 2008, Sydney: Centre for Health Informatics.
  • Pearson, S. (2008). What the papers don't tell you: Examining concomitant medicine use with pharmaceutical claims data. National Prescribing Service: Working with PBS Data Workshop 2008, Sydney: National Prescribing Service Ltd.
  • Lane, C., Ho, T., Healy, T., Pearson, S., Brown, M. (2007). Anyone for nephrology: Views of the Australian physician trainee. Inaugural Postgraduate Medical Education and Training Forum, Sydney: anzMET.
  • Hains, I., Pearson, S. (2007). Barriers to the use of CI-SCaT in Australian hospitals: A nurses perspective. Cancer Institute NSW Cancer Services and Education Research Meeting 2007, Sydney: Cancer Institute NSW.
  • Pearson, S. (2007). Investigating medicines use in cohort studies. Population Health and Use of Medicines Unit Annual Conference 2007, Sydney: University of NSW (UNSW).
  • Pearson, S., Ringland, C., Ward, R. (2007). Using administrative data sources for Australian pharmaceutical policy evaluation: potential and realities. St Vincent's Hospital Meeting 2007, Sydney: St Vincent's Hospital.
  • Mant, A., Lowinger, J., Hall, W., Ringland, C., Pearson, S. (2006). Changing use of statins in Australia: 1990-2004. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Rendle, V., Pearson, S., Ringland, C., Mant, A., Day, R., Kelman, C., Henry, D. (2006). Investigating minor analgesic use in Australian veterans: Prevention, promotion, possibilities. Department of Veterans' Affairs Research Meeting, 2006, Melbourne: Department of Veterans Affairs.
  • Van Gool, K., Gallego, G., Haas, M., Hall, J., Ward, R., Links, M., Stewart, B., Board, N., Pearson, S. (2006). Reporting economic evidence in cancer protocols: What decision makers really want. Health Technology Assessment International (HTAi 2006), Adelaide: University of Adelaide.
  • Lowinger, J., Ringland, C., Pearson, S., Mant, A. (2005). Australian ultilisation of statins and related expenditure: 1990-2004. 15th Annual St Vincent's and Mater Health Research Conference, Sydney: Mater Health.
  • Pearson, S. (2005). Data sources for estimating extent of use on the Pharmaceutical Benefits Scheme. Association of Regulatory and Clinical Scientists (ARCS) Congress 2005, Sydney: Association of Regulatory and Clinical Scientists.
  • Pearson, S. (2005). Designing and implementing surveys in areas of uncertainty. Association of Regulatory and Clinical Scientists (ARCS) Meeting 2005, Sydney: Association of Regulatory and Clinical Scientists.
  • Pearson, S. (2005). Health outcomes from QUM: Taking the next step in measuring the impacts. National Prescribing Service Planning Day 2005, Sydney: National Prescribing Service Ltd.
  • Pearson, S. (2005). Measuring population health outcomes from changes in community medicine use: A strategic approach. NSW Therapeutic Assessment Group Meeting 2005, Sydney: NSW Therapeutic Assessment Group.
  • Tan, E., Stark, H., Ward, R., Lowinger, J., Bichel-Findlay, J., Pearson, S. (2005). Understanding the information needs of clinicians treating cancer patients: A qualitative study. 32nd Annual Scientific Meeting of the Clinical Oncology Society of Australia, Brisbane, Australia: Wiley.
  • Pearson, S., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Cosler, L., Fanning, T., Salzman, C., Ross-Degnan, D. (2004). Regulatory surveillance of psychoactive drugs in Medicaid: evidence of racial bias. AcademyHealth 2004 Annual Research Meeting, San Diego, USA: AcademyHealth.
  • Grey, M., Pearson, S., Rolfe, I., Koeppen, B. (2003). Changing curriculum horses in mid-stream: Does curriculum reform influence recent graduate perceptions of preparedness for residency?. 26th Annual Meeting of the Society of General Internal Medicine, Vancouver, British Columbia: Blackwell Science.
  • Pearson, S. (2003). Racial differences in the impact of pharmaceutical regulation for benzodiazepines among medical enrollees in New York State. Fellowship in Pharmaceutical Policy Research and WHO Collaborating Center in Pharmaceutical Policy Annual Meeting 2003, Boston, USA: Harvard University.
  • Ross-Degnan, D., Pearson, S., Adams, A., Payson, A., Soumerai, S. (2002). Changing prescribing in managed care in the United States: A critical review of the evidence. National Medicines Symposium 2002: Linking People, Actions and Policy for Quality Use in Medicines, Canberra, Australia: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Pearson, S., Ross-Degnan, D., Payson, A., Soumerai, S. (2002). Changing Prescribing Practices in Managed Care. Centers for Education and Research in Therapeutics Annual Meeting, USA: Duke University.
  • Samandari, R., Pearson, S., Goldman, D., Ross-Degnan, D. (2002). Development of an assessment instrument measuring co-ordination of care and the culture of safety in teaching hospitals. NRSA Conference in Affiliation with the Academy of Health Services Research and Health Policy Conference, Washington DC: Academy of Health Services Research and Health Policy.
  • Pearson, S., Rolfe, I., Smith, A., Tasioulas, T., Weekes, L. (2000). A partnership between Australian medical schools and postgraduate training bodies to develop a national prescribing curriculum. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Grey, M., Rolfe, I., Pearson, S., Koeppen, B. (2000). Are graduates prepared for residency? A comparison of three cohorts of doctors. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Rolfe, I., Pearson, S., Bayley, S., Hart, A., Kelly, S., Sanson-Fisher, R., Groot, O., Henry, D. (2000). Interns' perceptions of core practice required at graduation: Is there a need for more training at medical school?. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Pearson, S., Rolfe, I., Ringland, C., Ardzejewska, K., Morgan, L., Procopis, P. (2000). Measuring the term experiences of junior doctors: Moving evaluation into the 21st century. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Pearson, S., Rolfe, I., Mazwai, E., Kwizera, E., Mkosi, B. (2000). South Africa's first medical graduates from an innovative problem-based curriculum: Are they prepared for practice?. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.

Report

  • Robertson, J., Newby, D., Moxley, A., Hains, I., Pearson, S. (2007). Improving the uptake of evidence-based drug information and decision support: Qualitative Study Findings.
  • Robertson, J., Newby, D., Moxley, A., Hains, I., Pearson, S. (2007). Improving the uptake of evidence-based drug information and decision support: Systematic Review Outcomes.
  • Tan, E., Stark, H., Lowinger, J., Ringland, C., Pearson, S. (2005). Information sources used to guide the pharmacological treatment practices in NSW public hospitals: A qualitative study.
  • Pearson, S., Ringland, C., Lowinger, J., Stark, H., Tan, E., Mant, A. (2005). Using pharmaceutical claims and wholesale data to investigate statins utilisation in the Australian population.
  • Pearson, S., Ringland, C., Lowinger, J., Kelman, C., Mant, A. (2005). Using secondary data sources to evaluate the impact of the Joint Heart Failure Program on health outcomes.
  • Pearson, S. (2004). AMR Infection Control Workshop and Field-Test: Trip Report, January 19-23, 2004. Rational Pharmaceutical Management Plus Program.
  • Pearson, S. (2000). Faculty of Medicine and Health Science Postgraduate Course Evaluation Review.

Other

  • Stavrou, E., Buckley, N., Pearson, S. (2011), Cancer, chemotherapy and depression in older patients.
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2010), Governance approval for multisite, non-interventional research: what can HoMER learn from the NSW experience?.
  • Hains, I., Pearson, S. (2010), Health Informatics Evaluation - A Case Study. Web-based systems for standardising cancer care.
  • Pearson, S. (2009), Evaluating the use and impact of cancer medicines in routine clinical care.
  • Pearson, S. (2009), Evaluating trastuzumab (Herceptin) use and outcomes in Australia.
  • Pearson, S. (2008), Evaluating Australian pharmaceutical access programs using health administrative data.
  • Pearson, S., Ringland, C., Ward, R. (2007), Making best use of secondary data sources for pharmaceutical policy evaluation in Australia: Hopes and realities.

2013

  • Langton, J., Pearson, S. (2013). Electronic Decision Support Systems for Prescribing: Challenges and Perspectives for Personalized Medicine. In I. S Vizirianakis (Eds.), Handbook of Personalized Medicine: Advances in Nanotechnology, Drug Delivery and Therapy. Pan Stanford Publishing.
  • Srasuebkul, P., Dobbins, T., Pearson, S. (2013). Validation of a proxy for estrogen receptor status in breast cancer patients using dispensing data. Asia Pacific Journal of Clinical Oncology.

2012

  • Banks, E., Pearson, S. (2012). A life-cycle approach to monitoring benefits and harms of medicines: Collection of high-quality data and management of risk are ongoing needs. Medical Journal of Australia, 197(6), 313-314.
  • Cohen, S., Lawson, J., Graudins, L., Pearson, S., Gazarian, M. (2012). Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality Use of Medicines. Journal of Paediatrics and Child Health, 48(6), 490-495.
  • Haywood, P., de Raad, J., van Gool, K., Haas, M., Gallego, G., Pearson, S., Faedo, M., Ward, R. (2012). Chemotherapy administration: Modelling the costs of alternative protocols. PharmacoEconomics, 30(12), 1173-1186.
  • Stavrou, E., Buckley, N., Olivier, J., Pearson, S. (2012). Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. BMJ Open, 2(3), 1-6.
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2012). Governance approval for multisite, non-interventional research: what can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience? Internal Medicine Journal, 42(2), 127-131.
  • Stavrou, E., Pesa, N., Pearson, S. (2012). Hospital discharge diagnostic and procedure codes for upper gastro-intestinal cancer: how accurate are they? BMC Health Services Research, 12(1), 1-7.
  • Hains, I., Ward, R., Pearson, S. (2012). Implementing a web-based oncology protocol system in Australia: evaluation of the first 3 years of operation. Internal Medicine Journal, 42(1), 57-64.
  • Langton, J., Pearson, S. (2012). Improving the quality of oncology guidelines and protocols. Asia Pacific Journal of Clinical Oncology, 8(3), 313-313.
  • Stavrou, E., Ward, R., Pearson, S. (2012). Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data. BMC Health Services Research, 12(1), 1-10.
  • Robertson, J., McElduff, P., Pearson, S., Henry, D., Inder, K., Attia, J. (2012). The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Services Research, 12, 1-11.
  • Stavrou, E., Lu, C., Buckley, N., Pearson, S. (2012). The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients. Annals of Oncology, 23(9), 2422-2428.
  • Mealing, N., Dobbins, T., Pearson, S. (2012). Validation and application of the death proxy in adult cancer patients. Pharmacoepidemiology and Drug Safety: an international journal, 21(7), 742-748.

2011

  • Stavrou, E., Buckley, N., Pearson, S. (2011), Cancer, chemotherapy and depression in older patients.
  • Lu, C., Srasuebkul, P., Ward, R., Pearson, S. (2011). Cardiotoxic Cancer Therapies in Australia: Which Patients are Assessed for Cardiac Function?. International Society of Pharmacoepidemiology Meeting 2011, Chicago, IL.
  • Robertson, J., Moxey, A., Newby, D., Gillies, M., Williamson, M., Pearson, S. (2011). Electronic information and clinical decision support for prescribing: State of play in Australian general practice. Journal Of Family Practice, 28(1), 93-101.
  • Joshi, V., Srasuebkul, P., Adelstein, B., Dobbins, T., Pearson, S. (2011). Estimating disease progression in patients with metastatic disease using prescribing data: A pilot validation study. Australian Epidemiological Association (AEA) Annual Conference 2011, Perth, WA.
  • Langton, J., Pearson, S. (2011). eviQ cancer treatments online: How does the web-based protocol system fare in a comprehensive quality assessment? Asia Pacific Journal of Clinical Oncology, 7(4), 357-363.
  • Langton, J., Pearson, S. (2011). Online Resources for Cancer Care: A Quality Assessment of Evidence-Based Guidelines and Protocols. 33rd Annual Meeting of the Society for Medical Decision Making SMDM 2011.
  • Lu, C., Srasuebkul, P., Drew, A., Ward, R., Pearson, S. (2011). Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Internal Medicine Journal, (Online preview).
  • Lu, C., Srasuebkul, P., Drew, A., Ward, R., Pearson, S. (2011). Spillover effects of prescribing restrictions for trastuzumab in Australia. Third International Conference for Improving Use of Medicines.
  • Harris, C., Ward, R., Dobbins, T., Drew, A., Pearson, S. (2011). The efficacy of HER2 targeted agents in metastatic breast cancer: A meta-analysis. Annals of Oncology, 22, 1308-1317.
  • Pearson, S., Srasuebkul, P., Dobbins, T., Lu, C., Ward, R. (2011). The Impact of Evidence-Based Subsidy Restrictions on Lapatinib Use and Outcomes. International Society of Pharmacoepidemiology Meeting 2011, Chicago, IL.
  • Pearson, S., Srasuebkul, P., Lu, C., Dobbins, T., Ward, R. (2011). The impact of evidence-based subsidy restrictions on prescriber behaviour and patient outcomes: A case study of lapatinib for the treatment of HER2+ metastatic breast cancer. Third International Conference for Improving Use of Medicines.
  • Pearson, S., Drew, A., Langton, J. (2011). The quality of a local web-based oncology protocol system: how does eviQ compare to similar websites internationally?. Medicines Management 2011, the 37th Society of Hospital Pharmacists of Australia (SHPA) National Conference.
  • Langton, J., Drew, A., Mellish, L., Olivier, J., Ward, R., Pearson, S. (2011). The quality of web-based oncology guidelines and protocols: how do international sites stack up? British Journal of Cancer, 105(8), 1166-1172.
  • Stavrou, E., Buckley, N., Lu, C., Pearson, S. (2011). The Role of Comorbidity in the Uptake of Chemotherapy and Cancer Survival. International Society of Pharmacoepidemiology Meeting 2011, Chicago, IL.
  • Stavrou, E., Vagdic, C., Loxton, D., Pearson, S. (2011). The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiology, 35, e75-e80.

2010

  • Pearson, S. (2010). Analysis of outcomes from trastuzumab (Herceptin) use in Australia. Combining Health Economics and Econometrics for Technology Assessment in Australia Annual Investigators Meeting, Sydney.
  • Cohen, S., Lawson, J., Graudins, L., Pearson, S., Gazarian, M. (2010). Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality Use of Medicines (QUM). National Medicines Symposium 2010, Melbourne.
  • Moxey, A., Robertson, J., Newby, D., Hains, I., Williamson, M., Pearson, S. (2010). Computerized clinical decision support for prescribing: provision does not guarantee uptake. Journal of the American Medical Informatics Association, 17(1), 25-33.
  • Dobbins, T., Srasuebkul, P., Stavrou, E., Pearson, S. (2010). Concurrentplot: a SAS macro to graphically display concurrent pharmaceutical use based on claims data. 5th Asian Meeting of the International Society of Pharmacoepidemiology, Tokyo, Japan: International Society for Pharmacoepidemiology.
  • Chen, K., He, J., Or, M., Srasuebkul, P., Pearson, S. (2010). Exploring the differences in resource utilisation for breast cancer chemotherapy in public and private hospitals in NSW. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2010), Governance approval for multisite, non-interventional research: what can HoMER learn from the NSW experience?.
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2010). Governance approval for multisite, non-interventional research: what can HoMER learn from the NSW experience?. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Hains, I., Pearson, S. (2010), Health Informatics Evaluation - A Case Study. Web-based systems for standardising cancer care.
  • Harris, C., Pearson, S., Dobbins, T., Drew, A., Ward, R. (2010). HER2 targeted agents improve overall survival in HER2+ metastatic breast cancer (MBC): A meta-analysis. Medical Oncology Group of Australia Annual Scientific Meeting, Sydney, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Stavrou, E., Dobbins, T., Lu, C., Srasuebkul, P., Pearson, S. (2010). Lack of uptake of chemotherapy for colorectal cancer in Australian veterans. 5th Asian Meeting of the International Society of Pharmacoepidemiology, Tokyo, Japan: International Society for Pharmacoepidemiology.
  • Pearson, S. (2010). More is better: Durations of trastuzumab therapy in Phase III clinical trials for HER2 positive metastatic breast cancer. National Medicines Symposium 2010, Melbourne.
  • Pearson, S., Srasuebkul, P., Stavrou, E., Ward, R., Dobbins, T. (2010). New HER2 therapies for metastatic breast cancer: Are prescribers the obstacle to access in Australia?. International Society of Pharmacoepidemiology 5th Asian Meeting, Tokyo.
  • de Raad, J., van Gool, K., Haas, M., Haywood, P., Faedo, M., Gallego, G., Pearson, S., Ward, R. (2010). Nursing takes time: workload associated with administering cancer protocols. Clinical Journal of Oncology Nursing, 14(6), 735-741.
  • Stavrou, E., Mealing, N., Dobbins, T., Pearson, S. (2010). Patterns of drug treatment for colorectal cancer (CRC) in New South Wales. Australian Epidemiological Association (AEA) Annual Conference 2010, Sydney, NSW.
  • Pearson, S., Chin, M., Faedo, M., Ward, R. (2010). Rationale for treatment durations of targeted cancer agents. Lancet Oncology, 11(12), 1113-1115.
  • Srasuebkul, P., Pearson, S., Harris, C., Ward, R., Dobbins, T. (2010). The impact of oestrogen receptor (ER) status on overall survival of metastatic breast cancer patients receiving trastuzumab in Australia. 16th Annual Japanese Society for Pharmacoepidemiology Meeting and the 5th Annual Asian Conference on Pharmacoepidemiology, Japan: ACPE.
  • Robertson, J., Walkom, E., Pearson, S., Hains, I., Williamsone, M., Newby, D. (2010). The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. International Journal of Pharmacy Practice, 18(2), 69-87.
  • Pearson, S., Srasuebkul, P., Harris, C., Ward, R., Dobbins, T. (2010). Trastuzumab (T) treatment outcomes according to concomitant chemotherapy regimen: Overall survival (OS) of HER2+ metastatic breast cancer (MBC) patients. 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Brighton, UK: International Society for Pharmacoepidemiology.
  • Srasuebkul, P., Pearson, S., Harris, C., Ward, R., Dobbins, T. (2010). Trastuzumab (T) treatment outcomes according to estrogen receptor (ER) status: Overall survival (OS) of HER2+ metastatic breast cancer (MBC) patients. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • He, J., Or, M., Chen, K., Srasuebkul, P., Pearson, S. (2010). Treatment pathways and resource utilisation in advanced/metastatic non-small-cell lung cancer patients undergoing chemotherapy. Sydney Cancer Conference 2010, Sydney, Australia: University of Sydney.
  • Mealing, N., Pearson, S., Srasuebkul, P., Stavrou, E., Dobbins, T. (2010). Validation and application of a death proxy in metastatic cancer patients. 5th Asian Meeting of the International Society of Pharmacoepidemiology, Tokyo, Japan: International Society for Pharmacoepidemiology.
  • Mealing, N., Dobbins, T., Srasuebkul, P., Stavrou, E., Pearson, S. (2010). Validation of a death proxy in adult cancer patients. Australian Epidemiological Association (AEA) Annual Conference 2010, Sydney, NSW.
  • Stavrou, E., Loxton, D., Vajdic, C., Pearson, S. (2010). Validation of self-reported cancer and predictors of false reports in Australian women. Australian Epidemiological Association (AEA) Annual Conference 2010, Sydney, NSW.
  • Pearson, S. (2010). What are the secrets to a successful health services research grant application?. HSRAANZ Workshop 2010, Sydney, NSW.

2009

  • Pearson, S. (2009). Application of Pharmacoepidemiology Research for Policy Making. 4th Asian Conference on Pharmacoepidemiology, Taiwan.
  • Pearce, A., Haas, M., Haywood, P., van Gool, K., Gallego, G., Pearson, S. (2009). Chemotherapy, adverse events and costs. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Pearson, S. (2009). Current research in cancer pharmacoepidemiology. 6th Annual 45 and Up Study Collaborators Meeting, Sydney.
  • Pearson, S., Moxey, A., Robertson, J., Hains, I., Williamson, M., Reeve, J., Newby, D. (2009). Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Services Research, 9.
  • Pearson, S. (2009). Economic modelling applied to cancer treatment protocols - EM-CAP. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Faedo, M., Pearson, S., Bastick, P., van Gool, K., Haywood, P., Haas, M., Ward, R. (2009). Elements of cancer care study: Tracking resource utilisation and costs in a cohort of NSW cancer patients. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.
  • Pearson, S. (2009). Ethics approval for data linkage studies: What really counts?. Health Data Linkage Workshop 2009, Newcastle, NSW.
  • Pearson, S. (2009), Evaluating the use and impact of cancer medicines in routine clinical care.
  • Pearson, S. (2009), Evaluating trastuzumab (Herceptin) use and outcomes in Australia.
  • Robertson, J., Pearson, S. (2009). Improving the uptake of drug information and decision support. National Prescribing Service Research and Development Working Group 2009, Sydney.
  • Garvey, G., Rolfe, I., Pearson, S., Treloar, C. (2009). Indigenous Australian medical students' perceptions of their medical school training. Medical Education, 43(11), 1047-1055.
  • Hains, I., Fuller, J., Ward, R., Pearson, S. (2009). Standardizing care in medical oncology: Are web-based systems the answer? Cancer, 115(23), 5579-5588.
  • Robertson, J., McElduff, P., Pearson, S., Henry, D., Inder, K., Attia, J. (2009). The burden of heart failure hospitalisations in NSW. Health Data Linkage Workshop 2009, Newcastle, NSW.
  • Pearson, S., Chin, M., Ward, R. (2009). The financially tolerable dose: A new concept in clinical trial design?. 25th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Providence, USA: International Society for Pharmacoepidemiology.
  • Pearson, S. (2009). Using health administrative data to evaluate pharmaceutical access programs in Australia. UNSW Psychosocial Research Group, Sydney.
  • Pearson, S., Faedo, M., van Gool, K., Haas, M., Ward, R. (2009). Using routinely collected health data to inform economic models of cancer care. 6th Health Services and Policy Research Conference, Brisbane: Faculty of Health Sciences, University of Sydney.

2008

  • Hains, I., Pearson, S. (2008). A nurses perspective on barriers to the uptake of CI-SCaT in Australian hospitals. CI-SCaT Nurses Reference Group Workshop 2008, Sydney: Cancer Institute NSW.
  • Cohen, S., Lawson, J., Graudins, L., Gazarian, M., Pearson, S. (2008). Anticonvulsant prescribing for the Australian paediatric population. TOW Research Awards, Sydney: TOW Society.
  • Hains, I., Bichel-Findlay, J., Rushton, S., Booth, A., Ward, R., Pearson, S. (2008). Barriers to using web-based chemotherapy protocols in Australian hospitals - The nurse perspective. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Ringland, C., Pearson, S., Ward, R. (2008). Cardiovascular medicine use in women receiving trastuzumab for HER-2 positive metastatic breast cancer. Sydney Cancer Conference 2008 (SCC2008), Sydney: University of Sydney.
  • Cheong, L., Ward, R., Pearson, S. (2008). Dosing guidelines for cytotoxic cancer chemotherapy: Theory versus reality. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Moxey, A., Newby, D., Robertson, J., Williamson, M., Hains, I., Pearson, S. (2008). Electronic design support for prescribing decisions in primary care: Does it work?. General Practice and Primary Health Care Research Conference GP & PHC 2008, Hobart, Australia: Primary Health Care Research and Information Service.
  • Moxey, A., Newby, D., Robertson, J., Williamson, M., Hains, I., Pearson, S. (2008). Electronic design support for prescribing decisions: Does it work?. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Pearson, S. (2008), Evaluating Australian pharmaceutical access programs using health administrative data.
  • Hains, I., Ward, R., Pearson, S. (2008). Evaluating CI-SCaT use in NSW hospitals. Cancer Institute NSW Cancer Services and Education Research Meeting 2008, Sydney: Cancer Institute NSW.
  • Pearson, S. (2008). Evaluating medicines use outside trial conditions: Making best use of secondary health data. The 5th Annual Future of the PBS Conference, Sydney.
  • Pearson, S. (2008). Evaluating the impact on cancer interventions using secondary health data. University of New South Wales International Research Workshop 2008, Sydney: University of New South Wales.
  • Pearson, S. (2008). Getting your data linkage project through ethics the first time: A researcher and committee member perspective. University of Newcastle Health Data Linkage Meeting 2008, Newcastle: University of Newcastle.
  • Moxey, A., Pearson, S., Williamson, M., Gillies, M., Newby, D., Robertson, J. (2008). GPs' use of computer-based information sources in clinical practice - What, when, how?. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Moxey, A., Pearson, S., Williamson, M., Gillies, M., Newby, D., Robertson, J. (2008). GPs' use of computer-based information sources in clinical practice - What, when, how?. General Practice and Primary Health Care Research Conference GP & PHC 2008, Hobart, Australia: Primary Health Care Research and Information Service.
  • Lane, C., Healy, C., Ho, M., Pearson, S., Brown, M. (2008). How to attract a nephrology trainee: Quantitative questionnaire results. Nephrology, 13(2), 116-123.
  • Moxey, A., Pearson, S., Robertson, J., Hains, I., Williamson, M., Newby, D. (2008). Influences on the use of electronic decision support in prescribing. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Moxey, A., Pearson, S., Robertson, J., Hains, I., Williamson, M., Newby, D. (2008). Influences on the use of prescribing electronic decision support. General Practice and Primary Health Care Research Conference GP & PHC 2008, Hobart, Australia: Primary Health Care Research and Information Service.
  • Lu, C., Ross-Degnan, D., Soumerai, S., Pearson, S. (2008). Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Services Research, 8.
  • Pearson, S., Ringland, C., Ward, R. (2008). Lessons learnt from an evaluation of The Herceptin National Access Program for metastatic breast cancer. Sydney Cancer Conference 2008 (SCC2008), Sydney: University of Sydney.
  • Pearson, S., Ringland, C., Ward, R. (2008). Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer. 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management 2008, Copenhagen, Denmark: International Society for Pharmacoepidemiology.
  • Bastick, P., Faedo, M., Van Gool, K., Pearson, S., Haas, M., Ward, R. (2008). Rationing high cost cancer medicines: Building the evidence base to support local decision makers. MOGA/FRO/NZSO/NZACS Joint Scientific Meeting, Christchurch: Wiley.
  • Pearson, S., Lawrence, G. (2008). Research opportunities using linked health data. University of New South Wales Research Seminar 2008, Sydney: University of New South Wales.
  • Pearson, S. (2008). Rules and definitions in the analysis of PBS data. National Prescribing Service: Working with PBS Data Workshop 2008, Sydney: National Prescribing Service Ltd.
  • Ringland, C., Pearson, S., Ward, R. (2008). Survival of women treated with trastuzumab for HER-2 positive metastatic breast cancer: Estimating outcomes in clinical practice with administrative data. 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management 2008, Copenhagen, Denmark: International Society for Pharmacoepidemiology.
  • Hains, I., Bichel-Findlay, J., Rushton, S., Ward, R., Pearson, S. (2008). The use of web-based chemotherapy protocols in Australian hospitals: Barriers to their uptake - The nurse perspective. 11th Cancer Nurses Society of Australia Winter Congress, Gold Coast: Cancer Nurses Society of Australia.
  • Cohen, S., Lawson, J., Graudins, L., Gazarian, M., Pearson, S. (2008). Trends in anticonvulsant prescribing in the Australian paediatric population: 2002-2007. 23rd Epilepsy Society Australia Annual Scientific Meeting, Sydney, Australia: Epilepsy Society of Australia.
  • Ringland, C., Mant, A., McGettigan, P., Mitchell, P., Kelman, C., Buckley, N., Pearson, S. (2008). Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data. British Journal of Clinical Pharmacology, 66(5), 682-688.
  • Faedo, M., van Gool, K., Pearson, S., Haas, M., Ward, R. (2008). Using clinical and economic evidence to inform local decision making in cancer care. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Hains, I., Bichel-Findlay, J., Rushton, S., Booth, A., Ward, R., Pearson, S. (2008). Web-based chemotherapy protocols - A help or hindrance?. National Medicines Symposium 2008, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Hains, I., Rushton, S., Bichel-Findlay, J., Booth, A., Ward, R., Pearson, S. (2008). Web-based chemotherapy protocols - friend or foe?. Centre for Health Informatics Seminar Series 2008, Sydney: Centre for Health Informatics.
  • Pearson, S. (2008). What the papers don't tell you: Examining concomitant medicine use with pharmaceutical claims data. National Prescribing Service: Working with PBS Data Workshop 2008, Sydney: National Prescribing Service Ltd.

2007

  • Lane, C., Ho, T., Healy, T., Pearson, S., Brown, M. (2007). Anyone for nephrology: Views of the Australian physician trainee. Inaugural Postgraduate Medical Education and Training Forum, Sydney: anzMET.
  • Hains, I., Pearson, S. (2007). Barriers to the use of CI-SCaT in Australian hospitals: A nurses perspective. Cancer Institute NSW Cancer Services and Education Research Meeting 2007, Sydney: Cancer Institute NSW.
  • Kelman, C., Pearson, S., Day, R., Holman, C., Kliewer, E., Henry, D. (2007). Evaluating Medicines: let's use all the evidence. Internal Medicine Journal, 186(5), 249-252.
  • Robertson, J., Newby, D., Moxley, A., Hains, I., Pearson, S. (2007). Improving the uptake of evidence-based drug information and decision support: Qualitative Study Findings.
  • Robertson, J., Newby, D., Moxley, A., Hains, I., Pearson, S. (2007). Improving the uptake of evidence-based drug information and decision support: Systematic Review Outcomes.
  • Pearson, S. (2007). Investigating medicines use in cohort studies. Population Health and Use of Medicines Unit Annual Conference 2007, Sydney: University of NSW (UNSW).
  • Pearson, S., Ringland, C., Ward, R. (2007), Making best use of secondary data sources for pharmaceutical policy evaluation in Australia: Hopes and realities.
  • Pearson, S., Ringland, C., Kelman, C., Mant, J., Lowinger, J., Stark, H., Nichol, G., Day, R., Henry, D. (2007). Patterns of analgesic and anti-inflammatory medicine use by Australian veterans. Internal Medicine Journal, 37(12), 798-805.
  • Pearson, S., Ringland, C., Ward, R. (2007). Trastuzumab and metastatic breast cancer: Trastuzumab use in Australia - Monitoring the effect of an expensive medicine access program. Journal of Clinical Oncology, 25(24), 3688-3693.
  • Pearson, S., Ringland, C., Ward, R. (2007). Use of Trastuzumab for metastatic breast cancer in Australia: interpreting findings from a cohort of 1,469 women on a national access program versus 41 women treated by two medical oncologists. Journal of Clinical Oncology, 25(35), 5663-5664.
  • Pearson, S., Ringland, C., Ward, R. (2007). Using administrative data sources for Australian pharmaceutical policy evaluation: potential and realities. St Vincent's Hospital Meeting 2007, Sydney: St Vincent's Hospital.

2006

  • Mant, A., Lowinger, J., Hall, W., Ringland, C., Pearson, S. (2006). Changing use of statins in Australia: 1990-2004. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Tan, E., Stark, H., Lowinger, J., Ringland, C., Ward, R., Pearson, S. (2006). Information Sources used by New South Wales cancer clinicians: a qualitative study. Internal Medicine Journal, 36(11), 711-717.
  • Rendle, V., Pearson, S., Ringland, C., Mant, A., Day, R., Kelman, C., Henry, D. (2006). Investigating minor analgesic use in Australian veterans: Prevention, promotion, possibilities. Department of Veterans' Affairs Research Meeting, 2006, Melbourne: Department of Veterans Affairs.
  • Pearson, S., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L., Fanning, T., Gallagher, P., Ross-Degnan, D. (2006). Racial disparities in access after regulatory surveillance of benzodiazepines. Archives of Internal Medicine, 166(5), 572-579.
  • Van Gool, K., Gallego, G., Haas, M., Hall, J., Ward, R., Links, M., Stewart, B., Board, N., Pearson, S. (2006). Reporting economic evidence in cancer protocols: What decision makers really want. Health Technology Assessment International (HTAi 2006), Adelaide: University of Adelaide.

2005

  • Lowinger, J., Ringland, C., Pearson, S., Mant, A. (2005). Australian ultilisation of statins and related expenditure: 1990-2004. 15th Annual St Vincent's and Mater Health Research Conference, Sydney: Mater Health.
  • Pearson, S. (2005). Data sources for estimating extent of use on the Pharmaceutical Benefits Scheme. Association of Regulatory and Clinical Scientists (ARCS) Congress 2005, Sydney: Association of Regulatory and Clinical Scientists.
  • Pearson, S. (2005). Designing and implementing surveys in areas of uncertainty. Association of Regulatory and Clinical Scientists (ARCS) Meeting 2005, Sydney: Association of Regulatory and Clinical Scientists.
  • Pearson, S. (2005). Health outcomes from QUM: Taking the next step in measuring the impacts. National Prescribing Service Planning Day 2005, Sydney: National Prescribing Service Ltd.
  • Tan, E., Stark, H., Lowinger, J., Ringland, C., Pearson, S. (2005). Information sources used to guide the pharmacological treatment practices in NSW public hospitals: A qualitative study.
  • Pearson, S. (2005). Measuring population health outcomes from changes in community medicine use: A strategic approach. NSW Therapeutic Assessment Group Meeting 2005, Sydney: NSW Therapeutic Assessment Group.
  • Tan, E., Stark, H., Ward, R., Lowinger, J., Bichel-Findlay, J., Pearson, S. (2005). Understanding the information needs of clinicians treating cancer patients: A qualitative study. 32nd Annual Scientific Meeting of the Clinical Oncology Society of Australia, Brisbane, Australia: Wiley.
  • Pearson, S., Ringland, C., Lowinger, J., Stark, H., Tan, E., Mant, A. (2005). Using pharmaceutical claims and wholesale data to investigate statins utilisation in the Australian population.
  • Pearson, S., Ringland, C., Lowinger, J., Kelman, C., Mant, A. (2005). Using secondary data sources to evaluate the impact of the Joint Heart Failure Program on health outcomes.

2004

  • Pearson, S. (2004). AMR Infection Control Workshop and Field-Test: Trip Report, January 19-23, 2004. Rational Pharmaceutical Management Plus Program.
  • Rolfe, I., Ringland, C., Pearson, S. (2004). Graduate entry to medical school? Testing some assumptions. Medical Education, 38(7), 778-786.
  • Pearson, S., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Cosler, L., Fanning, T., Salzman, C., Ross-Degnan, D. (2004). Regulatory surveillance of psychoactive drugs in Medicaid: evidence of racial bias. AcademyHealth 2004 Annual Research Meeting, San Diego, USA: AcademyHealth.

2003

  • Grey, M., Pearson, S., Rolfe, I., Koeppen, B. (2003). Changing curriculum horses in mid-stream: Does curriculum reform influence recent graduate perceptions of preparedness for residency?. 26th Annual Meeting of the Society of General Internal Medicine, Vancouver, British Columbia: Blackwell Science.
  • Pearson, S., Ross-Degnan, D., Payson, A., Soumerai, S. (2003). Changing medication use in managed care: A critical review of the available evidence. American Journal of Managed Care, 9(11), 715-731.
  • Pearson, S. (2003). Racial differences in the impact of pharmaceutical regulation for benzodiazepines among medical enrollees in New York State. Fellowship in Pharmaceutical Policy Research and WHO Collaborating Center in Pharmaceutical Policy Annual Meeting 2003, Boston, USA: Harvard University.

2002

  • Pearson, S., Rolfe, I., Ringland, C., Kay-Lambkin, F. (2002). A comparison of practice outcomes of graduates from traditional and non-traditional medical schools in Australia. Medical Education, 36(10), 985-991.
  • Ross-Degnan, D., Pearson, S., Adams, A., Payson, A., Soumerai, S. (2002). Changing prescribing in managed care in the United States: A critical review of the evidence. National Medicines Symposium 2002: Linking People, Actions and Policy for Quality Use in Medicines, Canberra, Australia: Pharmaceutical Health and Rational Use of Medicines Committee.
  • Pearson, S., Ross-Degnan, D., Payson, A., Soumerai, S. (2002). Changing Prescribing Practices in Managed Care. Centers for Education and Research in Therapeutics Annual Meeting, USA: Duke University.
  • Samandari, R., Pearson, S., Goldman, D., Ross-Degnan, D. (2002). Development of an assessment instrument measuring co-ordination of care and the culture of safety in teaching hospitals. NRSA Conference in Affiliation with the Academy of Health Services Research and Health Policy Conference, Washington DC: Academy of Health Services Research and Health Policy.
  • Pearson, S., Rolfe, I., Smith, T. (2002). Factors influencing prescribing: An intern's perspective. Medical Education, 36(8), 781-787.
  • Pearson, S., Rolfe, I., Smith, T., O'Connell, D. (2002). Intern prescribing decisions: Few and far between. Education for Health, 15(3), 315-325.
  • Mooney, W., Cole, I., Albsoul, N., Pearson, S. (2002). Salvage vertical partial laryngectomy for radiation failure in early glottic carcinoma. ANZ Journal of Surgery, 72(10), 746-749.
  • Kay-Lambkin, F., Pearson, S., Rolfe, I. (2002). The influence of admissions variables on first year medical school performance: A study from Newcastle University. Medical Education, 36(2), 154-159.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C., Bayley, S., Hart, A., Kelly, S. (2002). Which common clinical conditions should medical students be able to manage by graduation? A perspective from Australian interns. Medical Teacher, 24(1), 16-22.

2001

  • Grey, M., Pearson, S., Rolfe, I., Kay, F., Powis, D. (2001). How do australian doctors with different pre-medical school backgrounds perform as interns? Education for Health, 14(1), 87-96.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C. (2001). Identifying medical school learning needs: A survey of Australian interns. Education for Health, 14(3), 395-404.
  • Clercq, L., Pearson, S., Rolfe, I. (2001). The relationship between previous tertiary education and course performance in first year medical students at Newcastle University. Education for Health, 14(3), 417-426.

2000

  • Pearson, S., Rolfe, I., Smith, A., Tasioulas, T., Weekes, L. (2000). A partnership between Australian medical schools and postgraduate training bodies to develop a national prescribing curriculum. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Garvey, G., Rolfe, I., Pearson, S. (2000). Agents for social change: The University of Newcastle's role in graduating Australian Aboriginal doctors. Focus on Health Professional Education: a multi-disciplinary journal, 2(2), 18-27.
  • Grey, M., Rolfe, I., Pearson, S., Koeppen, B. (2000). Are graduates prepared for residency? A comparison of three cohorts of doctors. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Treloar, C., McCall, N., Rolfe, I., Pearson, S., Garvey, G., Heathcote, A. (2000). Factors affecting progress of Australian and international students in a prolem-based learning medical course. Medical Education, 34(9), 708-715.
  • Pearson, S. (2000). Faculty of Medicine and Health Science Postgraduate Course Evaluation Review.
  • Pearson, S., Smith, A., Rolfe, I., Moulds, R., Shenfield, G. (2000). Intern prescribing for common clinical conditions. Advances in Health Sciences Education, 5(2), 141-150.
  • Rolfe, I., Pearson, S., Bayley, S., Hart, A., Kelly, S., Sanson-Fisher, R., Groot, O., Henry, D. (2000). Interns' perceptions of core practice required at graduation: Is there a need for more training at medical school?. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Enno, A., Mondy, P., Kerridge, R., Pearson, S. (2000). Investigating pathology utilisation by junior medical staff in a teaching hospital: a qualitative study. Australian and New Zealand Journal of Medicine, 30(2), 261-263.
  • Pearson, S., Rolfe, I., Ringland, C., Ardzejewska, K., Morgan, L., Procopis, P. (2000). Measuring the term experiences of junior doctors: Moving evaluation into the 21st century. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.
  • Pearson, S., Rolfe, I., Mazwai, E., Kwizera, E., Mkosi, B. (2000). South Africa's first medical graduates from an innovative problem-based curriculum: Are they prepared for practice?. 9th Ottawa Conference on Medical Education, Capetown, South Africa: Association for Medical Education in Europe.

1999

  • Rolfe, I., Pearson, S., Cleary, E., Gannon, C. (1999). Attitudes towards community medicine: a comparison of students from traditional and community-oriented medical schools. Medical Education, 33(8), 606-611.
  • Kerridge, I., Pearson, S., Rolfe, I., Lowe, M. (1999). Decision making in CPR. Medical Journal of Australia, 170, 45-46.
  • Kerridge, I., Pearson, S., Rolfe, I., Lowe, M., McPhee, J. (1999). Impact of written information on knowledge and preferences for cardiopulmonary resuscitation. Medical Journal of Australia, 171(5), 239-242.

1998

  • Rolfe, I., Gordon, F., Atherton, S., Pearson, S., Kay, F., Fardell, S. (1998). A system for maintaining the educational and training standards of junior doctors. Medical Education, 32(4), 426-431.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Fardell, S., Kay, F., Gordon, J. (1998). Measuring the hospital experiences of junior doctors. Medical Education, 32(3), 312-319.
  • Rolfe, I., Pearson, S., Fardell, S., Kay, F. (1998). Monitoring the performance of junior doctors in the first two years of postgraduate training. Education for Health, 11.
  • Pearson, S., Rolfe, I., Henry, R. (1998). The relationship between assessment measures at Newcastle Medical School (Australia) and performance ratings during internship. Medical Education, 32(1), 40-45.
Back to Top

Keywords

Ageing

Back to Top

For support on your academic profile contact Research Support.